Your browser doesn't support javascript.
loading
Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.
Lambert, Catherine; Dubois, Benedicte; Dive, Dominique; Lysandropoulos, Andreas; Selleslag, Dominik; Vanopdenbosch, Ludo; Van Pesch, Vincent; Vanwijmeersch, Bart; Janssens, Ann.
Afiliação
  • Lambert C; Department of Hematology, Cliniques Universitaires St Luc, Brussels, Belgium. catherine.lambert@uclouvain.be.
  • Dubois B; Department of Neurology, Universitaire Zienkenhuis Leuven, Leuven, Belgium.
  • Dive D; Departement of Neurology, CHU Liège, Esneux, Belgium.
  • Lysandropoulos A; Neuroimmunology - MS Unit, Neurology Department, CUB- Hôpital Erasme, Brussels, Belgium.
  • Selleslag D; Department of Hematology, AZ Sint-Jan, Brugge, Belgium.
  • Vanopdenbosch L; Department of Neurology, AZ Sint Jan, Brugge, Belgium.
  • Van Pesch V; Department of Neurology, Cliniques Universitaires St Luc, Brussels, Belgium.
  • Vanwijmeersch B; Departement of Neurology, Rehabilitation and MS Center, Overpelt, Belgium.
  • Janssens A; Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Acta Neurol Belg ; 118(1): 141, 2018 03.
Article em En | MEDLINE | ID: mdl-29500681
ABSTRACT
The article Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab a Belgian consensus, written by Lambert et al., was originally published electronically on the publisher's internet portal on 27 January 2018 without open access.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article